Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats

BACKGROUND: Robenacoxib (Onsior™) is a non-steroidal anti-inflammatory drug developed for canine and feline use for the control of pain and inflammation. It is available as both tablets and solution for injection. The objective of this study was to evaluate the safety of the interchangeable use of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Heit, Mark C., Stallons, L. Jay, Seewald, Wolfgang, Thompson, Caryn M, Toutain, Céline E., King, Stephen B., Helbig, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520961/
https://www.ncbi.nlm.nih.gov/pubmed/32988403
http://dx.doi.org/10.1186/s12917-020-02553-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520961/
https://www.ncbi.nlm.nih.gov/pubmed/32988403
http://dx.doi.org/10.1186/s12917-020-02553-7

Ejemplares similares